How should a patient with ST‑segment elevation in lead V1 (approximately 0.9 mV) and incomplete right bundle‑branch block be evaluated and managed?

Immediate Evaluation for Acute Coronary Syndrome vs. Brugada Syndrome

A patient with ST elevation of 0.93 mV (approximately 0.9 mV) in lead V1 with incomplete right bundle branch block (IRBBB) requires urgent evaluation to differentiate between acute myocardial infarction and Brugada syndrome, with the clinical context determining whether emergency reperfusion therapy is indicated.

Initial Diagnostic Approach

Assess Clinical Presentation Immediately

The distinction between STEMI and Brugada syndrome hinges on clinical context:

• If chest pain/discomfort is present with ongoing ischemic symptoms: Treat as STEMI until proven otherwise 1, 2
• If asymptomatic or incidental finding: Consider Brugada syndrome or other non-ischemic causes 3, 4

Critical ECG Analysis

For STEMI diagnosis with IRBBB 5:

• ST elevation ≥0.1 mV (1 mm) in 2 or more contiguous leads is the threshold for reperfusion therapy consideration
• Your V1 elevation of 0.93 mV exceeds this threshold
• However, IRBBB can produce ST elevation as a normal variant, particularly in V1-V2 4

Key differentiating features:

1. Check lead placement: Higher placement of V1-V2 electrodes can create false ST elevation with IRBBB 4

2. Examine contiguous leads: STEMI requires ST elevation in ≥2 contiguous leads 5, 6

   • Is there ST elevation in V2 as well?
   • Check for reciprocal ST depression in inferior or lateral leads (suggests STEMI)

3. Brugada pattern characteristics 3, 7, 8:

   • Type 1: Coved ST elevation ≥2 mm in V1-V2 with negative T-wave
   • Type 2: Saddleback pattern with ST elevation
   • IRBBB is the hallmark finding in Brugada syndrome

Management Algorithm

If Clinical Suspicion for Acute MI (Chest Pain Present)

Proceed with reperfusion evaluation 9, 1, 5:

1. Within 10 minutes of presentation 6:

   • Administer aspirin 160-325 mg
   • Sublingual nitroglycerin (if BP >90 mmHg, HR 50-100 bpm)
   • Morphine for pain relief
   • Oxygen only if SaO₂ <90% 2

2. Do not wait for cardiac biomarkers 10 - initiate reperfusion therapy based on ECG and clinical presentation

3. Reperfusion strategy:

   • Primary PCI is preferred if available within appropriate timeframe 1, 2
   • Fibrinolytic therapy if PCI unavailable and presentation <12 hours from symptom onset 9, 5

Important caveat: Bundle branch blocks (including incomplete RBBB) can obscure ST analysis 1, 5. The 2006 ACEP guidelines specifically state that "any type of BBB (right, left, and atypical – new or old) thought to be obscuring ST-segment analysis in patients with clinical presentation strongly suggestive of AMI" warrants assessment for reperfusion therapy 5.

If No Ischemic Symptoms (Asymptomatic Finding)

Evaluate for Brugada syndrome 3, 7:

1. Obtain detailed history:

   • Family history of sudden cardiac death <40 years
   • Personal history of syncope
   • Previous cardiac arrest
   • Fever, excessive alcohol, large meals as triggers

2. Repeat ECG:

   • Ensure proper lead placement (V1-V2 in 4th intercostal space)
   • Look for dynamic changes
   • Consider V7-V9 leads to exclude posterior MI 1, 2

3. Consider provocative testing: Sodium channel blocker challenge (ajmaline, flecainide, procainamide) may unmask type 1 Brugada pattern if clinical suspicion exists 3

4. Risk stratification if Brugada confirmed 3, 7:

   • High risk (ICD indicated): Cardiac arrest survivors, documented sustained VT
   • Intermediate risk (ICD should be considered): Spontaneous type 1 ECG + syncope
   • Lower risk: Asymptomatic with drug-induced pattern only (annual risk ~0.8%) 7

Common Pitfalls to Avoid

1. Do not dismiss ST elevation in V1 with IRBBB as benign if the patient has chest pain - this combination can represent acute MI 11, 12

2. Do not rely solely on programmed electrical stimulation for Brugada risk stratification - it has limited predictive value (positive predictive value only 50%) 13

3. Do not assume IRBBB is always benign - recent evidence shows both complete and incomplete RBBB associate with increased cardiovascular morbidity 11

4. Do not delay angiography in patients with ongoing ischemic symptoms even without classic STEMI criteria - some acute occlusions (circumflex, vein grafts) may not show typical ST elevation 1, 2

Specific Recommendations for Your Case

Given ST elevation of 0.93 mV in V1 with IRBBB:

• If symptomatic with chest pain: Activate STEMI protocol immediately, proceed to emergency catheterization 1, 6, 2
• If asymptomatic: Verify lead placement, obtain serial ECGs, check cardiac biomarkers, and evaluate for Brugada syndrome with appropriate risk stratification 3, 4, 7

The presence of IRBBB does not exclude acute MI and should not delay reperfusion therapy when clinical presentation suggests ongoing ischemia 5, 11.